ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
81,965
0,00%
Bitcoin
68 695,43
0,24%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Talis Biomedical Corporation (TLIS)

  7. Talis Biomedical Corporation (TLIS) Actualités

TLIS

Talis Biomedical (TLIS)

Talis Biomedical Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TLIS
DateHeureSourceTitreSymboleSociété
08/05/202414h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLISTalis Biomedical Corporation
26/01/202422h33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
14/11/202314h00GlobeNewswire Inc.Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashNASDAQ:TLISTalis Biomedical Corporation
10/08/202323h01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TLISTalis Biomedical Corporation
10/08/202322h05GlobeNewswire Inc.Talis Biomedical Announces Second Quarter 2023 Financial Results and Business UpdateNASDAQ:TLISTalis Biomedical Corporation
03/08/202314h00GlobeNewswire Inc.Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023NASDAQ:TLISTalis Biomedical Corporation
02/08/202314h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
02/08/202314h17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
02/08/202314h00GlobeNewswire Inc.Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)NASDAQ:TLISTalis Biomedical Corporation
27/07/202314h00GlobeNewswire Inc.New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product MenuNASDAQ:TLISTalis Biomedical Corporation
24/07/202314h00GlobeNewswire Inc.Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:TLISTalis Biomedical Corporation
05/07/202314h00GlobeNewswire Inc.Talis Biomedical Announces 1-for-15 Reverse Stock SplitNASDAQ:TLISTalis Biomedical Corporation
13/06/202322h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
09/06/202322h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TLISTalis Biomedical Corporation
23/05/202314h00GlobeNewswire Inc.Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent DirectorNASDAQ:TLISTalis Biomedical Corporation
11/05/202322h05GlobeNewswire Inc.Talis Biomedical Announces Business Update and First Quarter 2023 Financial ResultsNASDAQ:TLISTalis Biomedical Corporation
04/05/202314h00GlobeNewswire Inc.Talis Biomedical to Provide Business Update and Financial Results on May 11, 2023NASDAQ:TLISTalis Biomedical Corporation
28/04/202322h20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TLISTalis Biomedical Corporation
28/04/202322h15Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TLISTalis Biomedical Corporation
22/03/202321h05GlobeNewswire Inc.Talis Announces Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:TLISTalis Biomedical Corporation
10/03/202322h56Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TLISTalis Biomedical Corporation
10/03/202322h31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TLISTalis Biomedical Corporation
15/02/202312h01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TLISTalis Biomedical Corporation
16/11/202208h57TipRanksTalis Biomedical (TLIS) Gets a Sell from BTIGNASDAQ:TLISTalis Biomedical Corporation
03/11/202221h05GlobeNewswire Inc.Talis Biomedical Reports Third Quarter 2022 Financial ResultsNASDAQ:TLISTalis Biomedical Corporation
02/08/202222h05GlobeNewswire Inc.Talis Biomedical Provides Business Update and Reports Second Quarter Financial ResultsNASDAQ:TLISTalis Biomedical Corporation
24/05/202222h26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:TLISTalis Biomedical Corporation
12/05/202209h45TipRanksBTIG Sticks to Its Sell Rating for Talis Biomedical (TLIS)NASDAQ:TLISTalis Biomedical Corporation
10/05/202222h05GlobeNewswire Inc.Talis Biomedical Announces First Quarter 2022 Financial ResultsNASDAQ:TLISTalis Biomedical Corporation
26/04/202214h00GlobeNewswire Inc.Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022NASDAQ:TLISTalis Biomedical Corporation
 Showing the most relevant articles for your search:NASDAQ:TLIS

Dernières Valeurs Consultées

BIT
F17948
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés